and report compounded drugs to the FDA. The facilities must also comply with Current Good Manufacturing Practices ...

Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage biopharmaceutical company focused on harnessing the power of trained immunity for the prevention and ...

Sight Care is an all-new vision support complex that has become a topic of discussion in the market over the past few ...

so sites must reevaluate their quality and safety credentials and maintain a state of good manufacturing practice (GMP) readiness. Throughout the pandemic, the lack of FDA inspections has created ...

Indian contract research organizations (CROs) have become increasingly well-integrated with electronic systems as the US FDA issues new guidelines regarding electronic records and signatures in ...

Coriolis Pharma, a biopharma company specializing in R&D and GMP drug product development, recently announced the launch of a new U.S. entity and two novel platform services designed to accelerate ...

Hem Securities Ltd. is the book-running lead manager of the issue and Hem Finlease is the market maker. The grey market premium (GMP) on the Danish Power IPO was Rs 265 as of 8:28 p.m. on Oct. 22, ...

Hyundai Motor India's shares currently trading at a discount to the issue price of Rs 1,960. The grey market premium (GMP) stands at Rs 1,903, reflecting a -3% premium. If trends persist, the stock is ...

Hyundai Motor India is scheduled to finalise share allotment basis on Friday, October 18. Bidders will get the messages, alerts or emails for debit of their funds or revocations of their IPO ...

With the latest grey market premium (GMP) suggesting a discounted listing—at a 1.63% lower price than its IPO offering of Rs 1,960—the mood is cautious on allotment day. Despite the buzz around the ...

Hyundai Motor India shares are showing a weak trend in the unlisted market as the grey market premium (GMP) has dried. According to stock market experts, Hyundai IPO GMP today is ₹-33.